Guardion Health Sciences Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Guardion Health Sciences Inc in the second quarter 2024?
Guardion Health Sciences Inc achieved a return on average equity (ROE) of 77.24 % in its second quarter 2024 a new company high.

ROE has advanced compared to -77.3% in the first quarter 2024, due to net income growth.

Within the Major Pharmaceutical Preparations industry 4 other companies had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 91, from total ROE ranking in the first quarter 2024 at 2721.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter
Y / Y Equity Change	89.89 %	-59.75 %	2.88 %	-63.77 %	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in Millions	6	-5	0	-9	-10
Return On Equity (TTM)	77.24 %	-77.3 %	2 %	-117.06 %	-92.36 %
GHSI's Total Ranking	# 91	# 2721	# 1668	# 3417	# 3552
Equity (TTM) in Millions	14	3	8	8	7
Seq. Equity Change	302.75 %	-58.09 %	5.77 %	6.36 %	-14.63 %
Seq. Net Income Change	-	-	13.98 %	-	-

Back to GHSI Management Effectiveness >> GHSI's 5 Years Annual ROE >> Compare GHSI ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 5
Sector	# 19
Overall	# 91

Return On Equity Statistics
High	Average	Low
77.24 %	-67.9 %	-163.23 %
(Jun 30 2024)		(Dec 31 2019)

GHSI Annual Return On Equity	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021	(Dec 31 2020) 2020	(Dec 31 2019) 2019
Total Equity in Millions	8	8	22	9	12
Y / Y Equity Change	2.88 %	-64.49 %	161.86 %	-29.23 %	-
Net Income in Millions	0	-15	-25	-9	-11
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	1.94 %	-188.46 %	-110.98 %	-100.66 %	-90.41 %

Back to GHSI Management Effectiveness >> GHSI's 5 Years Annual ROE >> Compare GHSI ROE to its Competitors

Annual Roe Comment

In 2023 ROE improved to 1.94 % compared to the previous year, due to net income growth.

More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
GHSI's' Return on Equity at Yahoo Finance
GHSI's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for GHSI's Competitors
Subscribers only: Roe for Guardion Health Sciences Inc 's Suppliers
Subscribers only: Return On Equity for GHSI's Customers

Companies with similar Return On Equity at Jun 30 2024, within Healthcare Sector	ROE
Biomx Inc	209.80 %
Halozyme Therapeutics Inc	168.60 %
Alaunos Therapeutics Inc	157.51 %
Oak Woods Acquisition Corp	153.71 %
Viskase Holdings inc	118.96 %
Davita Inc	99.50 %
Roivant Sciences Ltd	91.17 %
Tenet Healthcare Corp	88.36 %
Mimedx Group Inc	86.80 %
Earth Science Tech Inc	82.87 %
Cardiff Lexington Corporation	82.47 %
Guardion Health Sciences Inc	77.24 %
Dariohealth Corp	74.64 %
Nrc Health	63.64 %
Entrada Therapeutics Inc	62.08 %
Eli Lilly And Company	60.30 %
Abbvie Inc	57.23 %
Idexx Laboratories Inc	57.03 %
Medpace Holdings Inc	55.14 %
Johnson and Johnson	54.01 %
Siga Technologies Inc	51.39 %
Pharmacyte Biotech Inc	51.37 %
Insulet Corporation	50.53 %
Waters Corporation	50.44 %
Amgen Inc	50.41 %
Entera Bio Ltd	49.93 %
Lantheus Holdings Inc	49.15 %
Collegium Pharmaceutical Inc	49.14 %
Carlisle Companies Incorporated	47.37 %
Zoetis Inc	46.66 %

Date modified: 2026-09-12T06:22:35+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.